tradingkey.logo

Coherus BioSciences Inc <CHRS.OQ> expected to post a loss of 13 cents a share - Earnings Preview

ReutersMar 7, 2025 8:30 PM
  • Coherus BioSciences Inc CHRS.OQ CHRS.O is expected to show a fall in quarterly revenue when it reports results on March 10 for the period ending December 31 2024

  • The Redwood City California-based company is expected to report a 48.4% decrease in revenue to $47.27 million from $91.52 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Coherus BioSciences Inc is for a loss of 13 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Coherus BioSciences Inc is $7.00​, above​ its last closing price of $1.00. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-0.16

-0.13

-0.01

Beat

92.5

Jun. 30 2024

-0.29

-0.29

-0.14

Beat

51.7

Mar. 31 2024

-0.25

-0.24

-0.32

Missed

-32.3​

Dec. 31 2023

-0.14

-0.12

-0.62

Missed

-420.3

​​Sep. 30 2023

-0.29

-0.27

-0.27

Met

1.7

Jun. 30 2023

-0.48

-0.48

-0.38

Beat

21.6​

Mar. 31 2023

-0.54

-0.57

-0.75

Missed

-31

Dec. 31 2022

-0.87

-0.84

-0.60

Beat

28.4

This summary was machine generated March 7 at 20:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI